Target intelligence / Profile preview

T lymphocyte and B lymphocyte (T cell and B cell)

Target
T cell and B cell
Molecular classification
Other (cell type)
01

Overview

T lymphocyte and B lymphocyte are two distinct subtypes of lymphocytes, a major class of white blood cells fundamental to the adaptive immune system[3][4][5][7][8]. - **T lymphocytes** are primarily responsible for cell-mediated immunity, recognizing and destroying infected or abnormal cells and orchestrating immune responses via cytokine release and helper functions[6][7]. - **B lymphocytes** mediate humoral immunity through production and secretion of antibodies, serving as precursors to plasma cells and memory B cells[1][8]. Both cell types express specific antigen receptors (TCR for T cells, BCR for B cells), are central to immune memory, and participate in nearly all aspects of adaptive immune defense, as well as many immune-mediated diseases[2][3][4][5][6][7][8]. Dysfunction or therapeutic modulation of these cells underlies numerous infectious, malignant, and immune-mediated conditions. Note: If you are seeking information about a specific therapeutic target, such as "CD20" (on B cells) or "PD-1" (on T cells), it is preferable to specify the precise molecule or receptor rather than the entire cell type. The entry "T lymphocytes and B lymphocytes" is not a standard pharmacological or molecular target, but classes of immune cells with diverse roles and many interacting surface molecules[3][4][8].

Other names
T cellB cellT lymphocyteB lymphocyteT helper cellCytotoxic T cellPlasma cellMemory B cell
02

Mechanism of action

Modulation or depletion of cell population (e.g., anti-CD20 monoclonal antibodies deplete B cells) Activation/inhibition of receptors (e.g., PD-1/PD-L1 blockade reactivates T cells) Immune suppression (e.g., calcineurin inhibitors suppress T cell activation) Adoptive cell transfer (infusion of engineered T cells)

03

Biological functions

Adaptive immune responseAntigen recognitionHumoral immunity (B cells)Cell-mediated immunity (T cells)Antibody production (B cells)Cytotoxicity (T cells)Immune regulationImmune memory formation
04

Disease associations

Cancer (targeted by immunotherapies, dysfunction can lead to lymphomas/leukemias)Infection (essential for pathogen clearance; immunodeficiency if defective)Autoimmunity (aberrant T or B cell activation can cause autoimmune disease)Inflammation (central role in chronic inflammation and immune-mediated disorders)
05

Safety considerations

Immunosuppression (increased risk of infection/malignancy when T or B cells are depleted)Cytokine release syndrome (T cell therapies)Autoimmune reactions (immune checkpoint inhibitors, CAR-T therapies)Hypogammaglobulinemia (prolonged B cell depletion)
06

Interacting drugs

Monoclonal antibodies (e.g., rituximab targets CD20 on B cells)

4 more in the full profile.

07

Biomarkers

CD3 (pan-T cell marker)CD19 or CD20 (pan-B cell markers)CD4, CD8 (T cell subset markers)Immunoglobulin levels (B cell function)T cell activation markers: CD25, CD69, HLA-DR

Beyond the preview

Go deeper on T lymphocyte and B lymphocyte (T cell and B cell).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T lymphocyte and B lymphocyte (T cell and B cell).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call